Analysis of the efficacy and influence factors for treatment of primary hepatocellular carcinoma by Huachansu tablets combined with transarterial chemoembolization
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 4
Abstract
Objective To evaluate the efficacy of Huachansu tablets combined with transarterial chemoembolization (TACE) for treatment of primary hepatocellular carcinoma (HCC) and prognostic influence factors. Methods One hundred and eight patients with HCC were recruited according to the inclusion and exclusion criteria. Patients were randomly divided into treatment group and control group. The treatment group was treated with Huachansu tablets combined with TACE, and the control group was treated with TACE alone, with overall survival time (OS) and progression-free survival time (PFS) as the evaluation indexes. The COX regression analysis was used to evaluate the survival and prognostic effects and their influence factors in both groups. Results A total of 108 HCC patients were enrolled. The OS was 13.5 months in treatment group and 9.2 months in control group; the PFS was 6.8 months in treatment group and 5.3 months in control group, and the differences were significant statistically (all P<0.05). Multivariate COX regression analysis showed that Child-Pugh grade and cirrhosis were the independent risk factors for PFS in HCC patients. Child-Pugh grade were the independent risk factors for OS in HCC patients. ALBI is a protective factor for OS in HCC patients. Conclusions The treatment of HCC by Huachansu tablets combined with TACE can delay the progression of HCC and prolong PFS and OS of the patients with HCC. Child-Pugh grade, cirrhosis status, and ALBI were important factors affecting the prognosis of the patients with HCC.
Authors and Affiliations
Chienshan CHENG, Tao ZHANG, Junwei WU, Huifeng GAO, Jingxian CHEN, Zhiqiang MENG
Keywords
Related Articles
- EP ID EP754706
- DOI 10.16139/j.1007-9610.2024.04.13
- Views 2
- Downloads 0
Research and guidelines interpretation of neoadjuvant therapy for resectable pancreatic cancer, promising or limited?
As a systemic disease, pancreatic cancer is highly malignant and has a high rate of recurrence and metastasis, which makes it particularly difficult in diagnosis, treatment and management. In recent years, with the conce...
New progression of radiomics in diagnosis of gastric cancer
Gastric cancer is a common entity of malignant tumor in China with the third cause of mortality and morbidity among all malignancies. In recent years, radiomics has emerged as a quantitative tool for imaging analysis wit...
<![CDATA[Skin thermal injury at site of hypodermic electrodes placed for intraoperative neuromonitoring during thyroidectomy: one case report]]>
<![CDATA[In order to reduce intraoperative recurrent laryngeal nerve injury, intraoperative neural monitoring(IONM) is widely used in thyroid-related surgery, especially in reoperations. However, some incidental injuries...
Critical care medicine and safety management of high-risk surgical patients
At present, although the mortality of most patients undergoing major surgery is very low, the increase of so-called high-risk surgery patients with high risk of postoperative complications and death brings new challenges...
Construction of a Nomogram model for personalized prediction of the risk of delayed postoperative bleeding after endoscopic submucosal dissection for early gastric cancer
[Objective] To analyze the influencing factors of delayed postoperative bleeding (DPPB) after endoscopic submucosal dissection (ESD) for early gastric cancer and construct a Nomogram model. [Methods] The clinical informa...